merged_africa-snakebite-treatment-access.txt


<question_number>1</question_number>
<answer>delayed antivenom administration beyond critical window</answer>

<question_number>2</question_number>
<answer>Indian antivenom targets krait venom incompatible with Kenyan puff adder hemotoxins</answer>

<question_number>3</question_number>
<answer>neurotoxins paralyzing victims and hemotoxins destroying clotting factors</answer>

<question_number>4</question_number>
<answer>ocular venom exposure mimics non-snakebite eye injuries</answer>

<question_number>5</question_number>
<answer>rainy season floods displace snakes while dry seasons drive them toward human resources</answer>

<question_number>6</question_number>
<answer>neurotoxic potency, front-fanged delivery efficiency, rapid systemic spread</answer>

<question_number>7</question_number>
<answer>cold chain failures delay treatment beyond fetal viability timeframes</answer>

<question_number>8</question_number>
<answer>tourniquet-induced ischemia increases amputation likelihood despite venom containment intent</answer>